Nebula II CBD is a slightly sativa-dominant hybrid, about 60 percent sativa and 40 percent indica, developed from a cross between the popular Nebula and a high-CBD unknown line. The breeders aimed to preserve Nebula’s potent effects while boosting CBD content, yielding a profile with THC typically in the 5-7% range and CBD levels reaching up to about 8%.
Visuals show medium-sized, cone-shaped buds with reddish-brown tones, contrasted by vibrant minty-green leaves and a dense layer of amber pistils. A coating of milky amber trichomes covers each nug, accompanied by a light, syrupy resin that adds noticeable stickiness. The aroma leans sweet and honeyed with fruity overtones and a subtle earthy edge, while the flavor follows a dessert-like path reminiscent of vanilla yogurt with granola and fruit jam, finishing with a pleasantly pungent aftertaste. The overall profile hints at berry, fruity and herbal notes, underscored by honeyed sweetness and a faint woodiness.
The Nebula II CBD effect trends toward mild, relaxing relief, well suited for a laid-back day and often favored by vapers. A gentle uplifting mood and improved focus can accompany a calming body sensation, helping to ease tension and pain in both mind and body. Therapeutically, it supports relief from chronic pain, inflammation, muscle spasms, and tremors, with potential benefits for arthritis, migraines, fatigue, asthma, and PTSD.